A U.S. jury on Tuesday found Bayer AG’s glyphosate-based weed killer to be a “substantial factor” in causing a man’s non-Hodgkin’s lymphoma, allowing the trial to proceed into a second phase on liability and damages.
Latest posts by Reuters News (see all)
- Russian air force plane lands in Venezuela: witness, website - June 24, 2019
- Iran’s hardline media say new U.S. sanctions based on ‘fabricated excuses’ - June 24, 2019
- Supreme Court allows foul language trademarks in F-word case - June 24, 2019